According to the research report titled ‘Global Therapeutic Protein Market 2022-2028’, available with MarketStudyReport, global therapeutic protein market is anticipated to expand at a CAGR of 7.8% over 2022-2028, to reach a valuation of USD 146 billion by the end of 2028.

According to reliable estimates, development of plasma-derived medicine, and growing prevalence of diseases such as metabolic disorders, cancer, genetic ailments, and immunological diseases are the major growth stimulants for global therapeutic protein market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042722/  

For the unversed, therapeutic proteins are medicines that are genetically modified versions of naturally existing human proteins. Therapeutic proteins can be used to replace a protein that is anomalous or insufficient. They can also help lessen the impact of disease or chemotherapy by improving the body's supply of healthy protein.

On the contrary, high costs associated with developing and manufacturing protein-based medicines is projected to limit industry expansion in the coming years.

Based on product terrain, worldwide therapeutic protein market is branched into peptide antibiotics, therapeutic enzymes, cytokines, coagulation factors, peptide hormones, vaccines, and monoclonal antibodies. In terms of process, the industry is divided into natural source, microbial fermentation, cell culture, and others.

On the regional out-front, the industry trends across North America, Europe, Asia Pacific, and rest of the world are scrutinized in the report.

Speaking of competitive arena, Takeda Pharmaceutical Company Limited, Sanofi S.A., Pfizer Inc., Novo Nordisk A/S, Novartis AG, Merck KGaA, Johnson & Johnson, Grifols S.A., GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Eli Lilly and Company, CSL Limited, Bristol-Myers Squibb Company, BioMarin Pharmaceutical Inc., Amgen Inc., Alexion Pharmaceuticals Inc., and AbbVie Inc. are the leading players in global therapeutic protein market.

In addition, the study tracks and analyses market competitive trends such as collaboration, mergers & acquisitions, distribution channels, and R&D activities. Furthermore, conclusions from Porter's Five Forces analysis are included to assist both current players and potential entrants in developing strategies that will provide better returns during the analysis period.